Quarterly report pursuant to Section 13 or 15(d)

Segment Information

v3.20.1
Segment Information
3 Months Ended
Mar. 31, 2020
Segment Information  
Segment Information

17. Segment Information

The Company operates in two reportable segments, Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development. The accounting policies of the Company’s segments are the same as those described in Note 2. The following tables summarize, for the periods indicated, operating results from continued operations by reportable segment:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pharmaceutical

 

    

 

 

 

 

 

 

and

 

 

 

($in thousands)

 

Dermatology

 

Biotechnology

 

 

 

 

 

Products

 

Product

 

 

 

Three Months Ended March 31, 2020

    

Sales

    

Development

    

Consolidated

Net revenue

 

$

11,946

 

$

972

 

$

12,918

Direct cost of goods

 

 

(3,810)

 

 

 —

 

 

(3,810)

Sales and marketing costs

 

 

(4,679)

 

 

 —

 

 

(4,679)

Research and development

 

 

 —

 

 

(15,117)

 

 

(15,117)

General and administrative

 

 

(953)

 

 

(9,887)

 

 

(10,840)

Other expense

 

 

(207)

 

 

(2,333)

 

 

(2,540)

Segment income (loss)

 

$

2,297

 

$

(26,365)

 

$

(24,068)

Segment assets

 

 

 

 

 

 

 

 

 

Intangible assets, net

 

 

7,022

 

 

 —

 

 

7,022

Tangible assets

 

 

23,550

 

 

198,187

 

 

221,737

Total segment assets

 

$

30,572

 

$

198,187

 

$

228,759

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pharmaceutical

 

 

 

 

 

 

 

 

and

 

 

 

 

 

Dermatology

 

Biotechnology

 

 

 

($ in thousands)

 

Products

 

Product

 

 

 

Three Months Ended March 31, 2019

    

Sales

    

Development

    

Consolidated

Net revenue

 

$

6,125

 

$

352

 

$

6,477

Direct cost of goods

 

 

(1,884)

 

 

 —

 

 

(1,884)

Sales and marketing costs

 

 

(3,493)

 

 

 —

 

 

(3,493)

Research and development

 

 

 —

 

 

(23,723)

 

 

(23,723)

General and administrative

 

 

(387)

 

 

(9,598)

 

 

(9,985)

Other expense

 

 

 —

 

 

16,353

 

 

16,353

Segment income (loss)

 

$

361

 

$

(16,616)

 

$

(16,255)

Segment assets

 

 

 

 

 

 

 

 

 

Intangible assets, net

 

 

1,183

 

 

 —

 

 

1,183

Tangible assets

 

 

9,896

 

 

189,459

 

 

199,355

Total segment assets

 

$

11,079

 

$

189,459

 

$

200,538